Cargando…

Activation of innate and adaptive immunity as an effective combined strategy for cancer immunotherapy

Detalles Bibliográficos
Autores principales:	Rakhmilevich, Alexander, Felder, Mildred, Lever, Lauren, Van De Voort, Tyler, Korman, Alan J, Gillies, Stephen D, Sondel, Paul M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649448/ http://dx.doi.org/10.1186/2051-1426-3-S2-P370

Ejemplares similares

Antitumor effects of anti-CD40/CpG immunotherapy combined with gemcitabine or 5- fluorouracil chemotherapy in the B16 melanoma model
por: Rakhmilevich, Alexander, et al.
Publicado: (2013)

Immunocytokine augments local and abscopal response and animal survival when added to radiation and CTLA-4 checkpoint inhibition in a murine melanoma model
por: Morris, Zachary S, et al.
Publicado: (2015)

In vivo synergy of radiation and hu14.18-IL2 immunocytokine results in a memory T cell response in a syngeneic murine melanoma model
por: Morris, Zachary S, et al.
Publicado: (2014)

Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
por: Voeller, Julie, et al.
Publicado: (2019)

Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors
por: Perez Horta, Zulmarie, et al.
Publicado: (2014)

Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma
por: Aiken, Taylor J, et al.
Publicado: (2022)

Impaired innate and adaptive immunity of accelerated-aged Klotho mice in sepsis
por: Inoue, S, et al.
Publicado: (2012)

Current and Potential Uses of Immunocytokines as Cancer Immunotherapy
por: Sondel, Paul M., et al.
Publicado: (2012)

Innate and adaptive immunity contribute to the anti-tumor mechanisms of action of OncoVEX(mGM-CSF)
por: Cooke, Keegan, et al.
Publicado: (2015)

Innate response cytokines in inflammatory synovitis: novel targets and strategies
por: McInnes, I, et al.
Publicado: (2003)

P19-50 LB. Role of vaccine-induced innate and adaptive immunity in controlling mucosal transmission of SIV in macaques
por: Sui, Y, et al.
Publicado: (2009)

Antibody blockade of semaphorin 4D breaks down barriers to enhance tumoricidal immune infiltration and supports rational immunotherapy combinations
por: Evans, Elizabeth E, et al.
Publicado: (2015)

Cyclophosphamide augments the efficacy of in situ vaccination in a mouse melanoma model
por: Tsarovsky, Noah, et al.
Publicado: (2023)

Demonstration of novel innate immune cells in psoriasis
por: Mak, R, et al.
Publicado: (2010)

Tumor immunologic heterogeneity influences response to radiation and combination immunotherapy
por: Aguilera, Todd, et al.
Publicado: (2015)

Poxvirus immunotherapies in combination with immune checkpoint inhibitors synergize to eliminate tumors in a mouse tumor model
por: Foy, Susan P, et al.
Publicado: (2013)

The innate immune system as a therapeutic target in arthritis
por: Corr, M, et al.
Publicado: (2003)

Tumor targeting of innate and adaptive immunity by the adoptive cell transfer of engineered T lymphocytes co-expressing iNKT and tumor-specific MHC-I TCRs
por: Tschumi, Benjamin O, et al.
Publicado: (2014)

Imprime PGG, an innate immunomodulator for cancer immunotherapy has the potential to modulate macrophages in the tumor and the spleen to an anti-tumor M1-like phenotype
por: Fraser, Kathryn, et al.
Publicado: (2015)

Engineering the immune response to "self" for effective cancer immunotherapy
por: Zhong, Shi, et al.
Publicado: (2014)

P11. Developing an immunotherapy strategy for the effective treatment of patients with Non Small Cell Lung Cancer (NSCLC): strategies to evaluate immunity in patients on clinical trials
por: Neuberger, M, et al.
Publicado: (2014)

Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies
por: Moudgil, Tarsem, et al.
Publicado: (2014)

Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist
por: Pieper, Alexander A., et al.
Publicado: (2023)

Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Rotman, Galit, et al.
Publicado: (2013)

Dipyridamole modulates the innate immune response during human endotoxemia
por: Ramakers, B, et al.
Publicado: (2011)

Delirium screening, prevention and treatment in the ICU: a systematic review of implementation strategies
por: Trogrlic, Z, et al.
Publicado: (2014)

Developing an immunotherapy strategy for the effective treatment of patients with squamous cell carcinoma of the head and neck
por: Moudgil, Tarsem, et al.
Publicado: (2013)

Roles of CD4+ T cells as mediators of antitumor immunity
por: Kravtsov, Dmitriy S., et al.
Publicado: (2022)

Development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of T cell mediated cytotoxicity
por: Malu, Shruti, et al.
Publicado: (2013)

Antibody effector function is regulated by a combination of adaptive and innate signals
por: Mahan, A, et al.
Publicado: (2012)

Combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation
por: Minev, Boris, et al.
Publicado: (2014)

Bacterial flagellin triggers myocardial innate immune responses and acute contractile failure
por: Rolli, Joelle, et al.
Publicado: (2008)

Innate antiviral immunity is impaired in young patients with hand foot and mouth diseases
por: Yang, Y
Publicado: (2011)

Influence of body mass index on the innate immune response during human endotoxemia
por: Van der Pluijm, R
Publicado: (2011)

Antibody targeted CpG for the immunotherapy of solid tumors
por: Epstein, Alan L, et al.
Publicado: (2015)

Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Levy, Ofer, et al.
Publicado: (2014)

Tumor hypoxia drives immune suppression and immunotherapy resistance
por: Ai, Midan, et al.
Publicado: (2015)

Combined radiotherapy and immunotherapy using CPG oligodeoxynucleotides and indolamine 2,3 dioxygenase (IDO) blockade
por: Monjazeb, Arta M, et al.
Publicado: (2013)

Exploitation of gamma delta T cells in cancer immunotherapy as combined antigen-presenters and cancer cell killers
por: Holmen Olofsson, Gitte, et al.
Publicado: (2014)

Adapting an immune competent mouse model for glioblastoma T cell therapy
por: Rodriguez-Cruz, Tania, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7oi58bs4gaenbaja7kt3hmcpa0